Renal cell carcinoma is one of the most common cancers worldwide. However, there still is a lack of awareness of the disease.
Bayer HealthCare and the Kidney Cancer Association (KCA) have therefore announced the European “Advances in Renal Cancer” Journalists’ Award 2011.
For the third time, the prize honours journalistic work, in which journalists cover the issue of renal cancer in a critical, but yet objective manner. It is endowed with the sum of Euro 7,500 and awarded to reports which have been published in print media, radio, television, or film.
“Malignant tumors in kidney cells are one of the most insidious types of cancer worldwide. They are often only diagnosed at a late stage and have a significant unmet medical need”, says Helmut Schäfers, Head of Corporate Communications Europe, Bayer HealthCare, Leverkusen, Germany.
“By announcing this award together with specialists in this field, we want to stimulate journalists to report on the disease and publish more information about renal carcinoma and current medical developments.”
Carrie Konosky, Director of Development & Public Affairs, Kidney Cancer Association, USA, explains: “Our objective is to raise awareness of the symptoms and risk factors of renal cancer and inform the public about new, diagnostic therapy options. That is why the media are an important partner for us.”